Myriad Genetics (MYGN) Enterprise Value Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Enterprise Value Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.99 Bn | 209.92 Bn | 8.34 Bn |
| 2 | Danaher | 140.41 Bn | 136.06 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.27 Bn | 46.08 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.81 Bn | 38.00 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.53 Bn | 37.45 Bn | 1.44 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn |
| 7 | Illumina | 30.03 Bn | 28.86 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.67 Bn | 28.62 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.16 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Myriad Genetics | 294.69 Mn | 170.29 Mn | 137.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.51% |
| Dec 31, 2025 | -46.09% |
| Sep 30, 2025 | -45.55% |
| Jun 30, 2025 | 23.54% |
| Mar 31, 2025 | 11.98% |
| Dec 31, 2024 | 27.32% |
| Sep 30, 2024 | -15.76% |
| Jun 30, 2024 | 19.98% |
| Mar 31, 2024 | -32.53% |
| Dec 31, 2023 | -22.63% |
| Sep 30, 2023 | 54.86% |
| Jun 30, 2023 | 40.42% |
| Mar 31, 2023 | 70.57% |
| Dec 31, 2022 | 66.09% |
| Sep 30, 2022 | 47.79% |
| Jun 30, 2022 | -24.07% |
| Mar 31, 2022 | -51.85% |
| Dec 31, 2021 | -124.82% |
| Sep 30, 2021 | -128.30% |
| Jun 30, 2021 | 24.47% |